Resultados da pesquisa - Andrea Issberner
- A mostrar 1 - 6 resultados de 6
-
1
Early alpha-lipoic acid therapy protects from degeneration of the inner retinal layers and vision loss in an experimental autoimmune encephalomyelitis-optic neuritis model Por Michael Dietrich, Niklas Helling, Alexander Hilla, Annemarie Heskamp, Andrea Issberner, Thomas Hildebrandt, Zippora Kohne, Patrick Küry, Carsten Berndt, Orhan Aktaş, Dietmar Fischer, Hans‐Peter Hartung, Philipp Albrecht
Publicado em 2018Artigo -
2
Positive allosteric modulation of AMPA receptors via PF4778574 leads to reduced demyelination and clinical disability in experimental models of multiple sclerosis Por Mustafa Sindi, Michael Dietrich, Diana Klees, Joel Gruchot, Christina Hecker, John Silbereis, Andrea Issberner, Hans Hartung, Tobias Ruck, Holger Stark, Thomas Kurz, Patrick Küry, Sven G. Meuth, A Philipp
Publicado em 2025Artigo -
3
Effects of dimethyl fumarate on neuroprotection and immunomodulation Por Philipp Albrecht, Imane Bouchachia, Norbert Goebels, Nadine Henke, Harald H. Hofstetter, Andrea Issberner, Zsuzsa Kovács, Jan Lewerenz, Dmitrij Lisak, Pamela Maher, Anne K. Mausberg, Kim Quasthoff, Corinna Zimmermann, Hans‐Peter Hartung, Axel Methner
Publicado em 2012Artigo -
4
Monitoring retinal changes with optical coherence tomography predicts neuronal loss in experimental autoimmune encephalomyelitis Por Andrés Cruz-Herranz, Michael Dietrich, Alexander Hilla, Hao Yiu, Marc H. Levin, Christina Hecker, Andrea Issberner, Angelika Hallenberger, Christian Cordano, Klaus Lehmann‐Horn, Lisanne J. Balk, Orhan Aktaş, Jens Ingwersen, Charlotte von Gall, Hans-Peter Hartung, Scott S. Zamvil, Dietmar Fischer, Philipp Albrecht, Ari Green
Publicado em 2019Artigo -
5
Increased Remyelination and Proregenerative Microglia Under Siponimod Therapy in Mechanistic Models Por Michael Dietrich, Christina Hecker, Elodie Martin, Dominique Langui, Michael Gliem, Bruno Stankoff, Catherine Lubetzki, Joel Gruchot, Peter Göttle, Andrea Issberner, Milad Nasiri, Pamela Ramseier, Christian Beerli, Sarah Tisserand, Nicolau Beckmann, Derya R. Shimshek, Patrick Petzsch, David Akbar, Bodo Levkau, Holger Stark, Karl Köhrer, Hans‐Peter Hartung, Patrick Küry, Sven Günther Meuth, Marc Bigaud, Bernard Zalc, Philipp Albrecht
Publicado em 2022Artigo -
6
Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis Por Michael Dietrich, Valeria Koska, Christina Hecker, Peter Göttle, Alexander Hilla, Annemarie Heskamp, Klaudia Lepka, Andrea Issberner, Angelika Hallenberger, Christine Baksmeier, Julia Steckel, Lisanne J. Balk, Benjamin Knier, Thomas Korn, Joachim Havla, Elena H. Martínez‐Lapiscina, Núria Solà‐Valls, Praveena Manogaran, Elisabeth Olbert, Sven Schippling, Andrés Cruz-Herranz, Hao Yiu, Julia Button, Natalia Gonzalez Caldito, Charlotte von Gall, Anne K. Mausberg, Mark Stettner, Hanna Zimmermann, Friedemann Paul, Alexander U. Brandt, Patrick Küry, Norbert Goebels, Orhan Aktaş, Carsten Berndt, Shiv Saidha, Ari Green, Peter A. Calabresi, Dietmar Fischer, Hans-Peter Hartung, Philipp Albrecht
Publicado em 2020Artigo
Ferramentas de pesquisa:
Assuntos relacionados
Immunology
Multiple sclerosis
Biology
Medicine
Neuroscience
Optic neuritis
Experimental autoimmune encephalomyelitis
Internal medicine
Ophthalmology
Optic nerve
Pathology
Central nervous system
Inflammation
Myelin
Myelin oligodendrocyte glycoprotein
Neuroprotection
Pharmacology
Retina
Retinal
Retinal ganglion cell
4-Aminopyridine
AMPA receptor
Allosteric regulation
Atrophy
Audiology
Biochemistry
Cell
Cell biology
Chemistry
Cytokine